19Nov 2023
Study Reveals Association of HMGCR inhibition with Rheumatoid Arthritis

Study Reveals Association of HMGCR inhibition with Rheumatoid Arthritis

A recent study delved into the correlation between hydroxymethylglutaryl coenzyme A reductase (HMGCR) inhibition and rheumatoid arthritis (RA) using drug-target Mendelian randomization (MR) and genetic colocalization analyses. Employing genetic instruments such as expression quantitative trait loci (eQTLs) and genetic variants associated with low-density lipoprotein cholesterol (LDL-C), the study found a significant association between genetically proxied expression of eQTL and a lower risk of RA. Additionally, HMGCR-mediated LDL was negatively associated with RA risk, indicating a potential causal relationship. These findings emphasize the need for further research on alternative approaches to HMGCR inhibitors in RA management.

  • #rheumatology

Like

Save

Share